Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Craig

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Annals of the American Thoracic Society|July 1, 2025
Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: Real-World EvidenceAlex E Henney, David R Riley, Matthew Anson, et al.
ERJ Open Research|August 4, 2020
Implementation of a computer-guided consultation in the assessment of suspected obstructive sleep apnoea syndromeBiswajit Chakrabarti, Nadia Lewis-Burke, Mike Pearson, et al.
Chronic Respiratory Disease|May 21, 2015
Serum urate and obstructive sleep apnoea in severe obesityIan W Seetho, Robert J Parker, Sonya Craig, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|May 17, 2015
Effect of CPAP on Cardiac Function in Minimally Symptomatic Patients with OSA: Results from a Subset of the MOSAIC Randomized TrialSonya Craig, Ilias Kylintireas, Malcolm Kohler, et al.
Chest|May 25, 2013
CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trialMalcolm Kohler, Sonya Craig, Justin C T Pepperell, et al.
Diabetes, Obesity & Metabolism|November 12, 2024
The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomesDavid R Riley, Alex Henney, Matthew Anson, et al.
European Journal of Clinical Investigation|October 1, 2014
Urinary proteomics in obstructive sleep apnoea and obesityIan W Seetho, Justyna Siwy, Amaya Albalat, et al.
Sleep Science (Sao Paulo, Brazil)|October 21, 2015
Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatmentIan W Seetho, Adela Ramírez-Torres, Amaya Albalat, et al.
Eclinicalmedicine|September 30, 2024
Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysisJean-Louis Pépin, Philippe Lehert, Raoua Ben Messaoud, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Annals of the American Thoracic Society|July 1, 2025
Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: Real-World EvidenceAlex E Henney, David R Riley, Matthew Anson, et al.
ERJ Open Research|August 4, 2020
Implementation of a computer-guided consultation in the assessment of suspected obstructive sleep apnoea syndromeBiswajit Chakrabarti, Nadia Lewis-Burke, Mike Pearson, et al.
Chronic Respiratory Disease|May 21, 2015
Serum urate and obstructive sleep apnoea in severe obesityIan W Seetho, Robert J Parker, Sonya Craig, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|May 17, 2015
Effect of CPAP on Cardiac Function in Minimally Symptomatic Patients with OSA: Results from a Subset of the MOSAIC Randomized TrialSonya Craig, Ilias Kylintireas, Malcolm Kohler, et al.
Chest|May 25, 2013
CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trialMalcolm Kohler, Sonya Craig, Justin C T Pepperell, et al.
Diabetes, Obesity & Metabolism|November 12, 2024
The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomesDavid R Riley, Alex Henney, Matthew Anson, et al.
European Journal of Clinical Investigation|October 1, 2014
Urinary proteomics in obstructive sleep apnoea and obesityIan W Seetho, Justyna Siwy, Amaya Albalat, et al.
Sleep Science (Sao Paulo, Brazil)|October 21, 2015
Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatmentIan W Seetho, Adela Ramírez-Torres, Amaya Albalat, et al.
Eclinicalmedicine|September 30, 2024
Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysisJean-Louis Pépin, Philippe Lehert, Raoua Ben Messaoud, et al.
Pageof 2